Pallmann, H.
55  Ergebnisse:
Personensuche X
?
2

Practical guidance for planning resources required to suppo..:

Wason, J.M.S ; Dimairo, M ; Biggs, K...
https://eprints.whiterose.ac.uk/189879/1/s12916-022-02445-7.pdf.  , 2022
 
?
3

Practical guidance for running late-phase platform protocol..:

Love, SB ; Cafferty, F ; Snowdon, C...
https://eprints.whiterose.ac.uk/191295/1/s13063-022-06680-4.pdf.  , 2022
 
?
6

Procalcitonin Evaluation of Antibiotic use in COVID-19 Hosp..:

Euden, J ; Pallmann, P ; Grozeva, D...
https://eprints.whiterose.ac.uk/196260/1/mps-05-00095.pdf.  , 2022
 
?
 
?
9

Costs and staffing resource requirements for adaptive clini..:

Wilson, N ; Biggs, K ; Bowden, S...
https://discovery.ucl.ac.uk/id/eprint/10137055/1/Wilson-2021-Costs%20and%20staffing%20resource%20requir.pdf.  , 2021
 
?
10

Costs and staffing resource requirements for adaptive clini..:

Wilson, N ; Biggs, K ; Bowden, S...
https://eprints.whiterose.ac.uk/179736/1/Costs%20and%20staffing%20resource%20requirements%20for%20adaptive%20clinical%20trials.pdf.  , 2021
 
?
11

Use of Procalcitonin during the First Wave of COVID-19 in t..:

Powell, N ; Howard, P ; Llewelyn, MJ...
https://eprints.whiterose.ac.uk/173661/1/antibiotics-10-00516.pdf.  , 2021
 
?
13

A protocol for a randomised controlled, double-blind feasib..:

Cheney J. G. Drew ; Mark Postans ; Cateno Petralia...
http://link.springer.com/article/10.1186/s40814-019-0474-x.  , 2019
 
?
14

A protocol for a randomised controlled, double-blind feasib..:

Drew, Cheney ; Postans, Mark ; Petralia, Cateno...
Drew , C , Postans , M , Petralia , C , McNamara , R , Pallmann , P , Gillespie , D , Evans , L H , Muhlert , N , Winter , M , Hamandi , K & Gray , W 2019 , ' A protocol for a randomised controlled, double-blind feasibility trial investigating fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, Learning and Memory in Epilepsy (FLAME trial) ' , Pilot and Feasibility Studies . https://doi.org/10.1186/s40814-019-0474-x.  , 2019
 
1-15